133 related articles for article (PubMed ID: 37352082)
1. Analysis of clinical characteristics and prognostic factors of elderly patients with renal cell carcinoma based on the SEER database.
Peng X; Sun H; Wang L; Guo W; Zhao Z; Yang J
Medicine (Baltimore); 2023 Jun; 102(25):e34069. PubMed ID: 37352082
[TBL] [Abstract][Full Text] [Related]
2. Impact of pathologic lymph node-positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer.
Srivastava A; Rivera-Núñez Z; Kim S; Sterling J; Farber NJ; Radadia KD; Patel HV; Modi PK; Goyal S; Parikh R; Mayer TM; Saraiya B; Sadimin ET; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
Cancer; 2020 Jul; 126(13):2991-3001. PubMed ID: 32329899
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of laterality in renal cell carcinoma: A population-based study from the surveillance, epidemiology, and end results (SEER) database.
Guo S; Yao K; He X; Wu S; Ye Y; Chen J; Wu CL
Cancer Med; 2019 Sep; 8(12):5629-5637. PubMed ID: 31407495
[TBL] [Abstract][Full Text] [Related]
4. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
[TBL] [Abstract][Full Text] [Related]
5. Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States.
Patel HD; Gupta M; Joice GA; Srivastava A; Alam R; Allaf ME; Pierorazio PM
Eur Urol Oncol; 2019 Jul; 2(4):343-348. PubMed ID: 31277771
[TBL] [Abstract][Full Text] [Related]
6. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
7. Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma.
Shao Y; Xiong S; Sun G; Dou W; Hu X; Yang W; Lia T; Deng S; Wei Q; Zeng H; Li X
Cancer Med; 2020 Feb; 9(3):959-970. PubMed ID: 31840431
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Nomogram to Predict Distant Metastasis in Elderly Patients With Renal Cell Carcinoma.
Wang J; Zhanghuang C; Tan X; Mi T; Liu J; Jin L; Li M; Zhang Z; He D
Front Public Health; 2021; 9():831940. PubMed ID: 35155365
[TBL] [Abstract][Full Text] [Related]
9. A web-based prediction model for overall survival of elderly patients with early renal cell carcinoma: a population-based study.
Wang J; Tang J; Chen T; Yue S; Fu W; Xie Z; Liu X
J Transl Med; 2022 Feb; 20(1):90. PubMed ID: 35164796
[TBL] [Abstract][Full Text] [Related]
10. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
[TBL] [Abstract][Full Text] [Related]
11. Lymph Node Density as an Independent Prognostic Factor in Node-Positive Renal-Cell Carcinoma: Results From the Surveillance, Epidemiology, and End Results Program.
Liao X; Qiu S; Zheng X; Ai J; Jin X; Gong L; Bao Y; Jin K; Li H; Yang L; Wei Q
Clin Genitourin Cancer; 2019 Oct; 17(5):e968-e980. PubMed ID: 31229458
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
13. [Multivariate analysis of prognostic factors in renal cell carcinoma].
Wang Y; Huang C; Wu Y; Gao G; Xin Y; Lin Z; Li X; Pan M
Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):442-4. PubMed ID: 11832079
[TBL] [Abstract][Full Text] [Related]
14. A Population Study to Identify Candidates for Cytoreductive Nephrectomy in Patients with Metastatic Sarcomatoid Renal Cell Carcinoma from the Surveillance, Epidemiology, and End Results (SEER) Database.
Ji B; Li D; Fu S; Zhang Z; Yang T; Wu Y; Zuo Y; Xu Z; Yu N
Med Sci Monit; 2020 Jun; 26():e921297. PubMed ID: 32516796
[TBL] [Abstract][Full Text] [Related]
15. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics and outcomes of synchronous renal cell carcinoma and urothelial carcinoma: A population-based analysis.
Wu K; Liu X; Wang Y; Wang X; Li X
Front Public Health; 2022; 10():994351. PubMed ID: 36388369
[TBL] [Abstract][Full Text] [Related]
17. Expression of phosphorylated p21-activated kinase 4 is associated with aggressive histologic characteristics and poor prognosis in patients with surgically treated renal cell carcinoma.
Kang HW; Piao XM; Lee HY; Kim K; Seo SP; Ha YS; Kim YU; Kim WT; Kim YJ; Lee SC; Kim WJ; Shin EY; Kim EG; Yun SJ
Investig Clin Urol; 2021 Jul; 62(4):399-407. PubMed ID: 34085786
[TBL] [Abstract][Full Text] [Related]
18. Reassessment of the 1997 TNM classification system for renal cell carcinoma.
Elmore JM; Kadesky KT; Koeneman KS; Sagalowsky AI
Cancer; 2003 Dec; 98(11):2329-34. PubMed ID: 14635066
[TBL] [Abstract][Full Text] [Related]
19. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of renicapsular involvement in Stages I and II renal cell carcinoma from the morphological and prognostic point of view.
May M; Brookman-Amissah S; Roigas J; Gilfrich CP; Pflanz S; Hoschke B; Gunia S
Urol Oncol; 2010; 28(3):274-9. PubMed ID: 18805709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]